Diabetes Management Therapy Advisor
    1.
    发明公开

    公开(公告)号:US20240347213A1

    公开(公告)日:2024-10-17

    申请号:US18733065

    申请日:2024-06-04

    申请人: GLYTEC, LLC

    摘要: A method includes obtaining training data for a plurality of patients of a patient population. The training data includes training blood glucose history data including treatment doses of insulin administered by the patients of the patient population and one or more outcome attributes associated with each treatment dose. The method also includes identifying, for each patient of the patient population, one or more optimum treatment doses of insulin from the treatment doses yielding favorable outcome attributes. The method also includes receiving patient-state information for the treated patient, determining a next recommended treatment dose of insulin for the treated patient based on one or more of the identified optimum treatment doses associated with the patients of the patient population having training patient-state information similar to the patient-state information for the treated patient, and transmitting the next recommended treatment dose to a portable device associated with the treated patient.

    Customizing healthcare app offerings based on clinical records

    公开(公告)号:US12106833B2

    公开(公告)日:2024-10-01

    申请号:US16235857

    申请日:2018-12-28

    摘要: Methods, computer readable media, and systems for providing a Unified Medical Record (UMR) Cloud Network that takes maintenance and access of patient-centric healthcare records to the next level by providing a healthcare-provider-specific app store in a healthcare web portal by utilizing Fast Healthcare Interoperability Resources (FHIR) resources are provided. The UMR Cloud Network serves as a patient web portal which hosts a provider-specific FHIR App Store. The FHIR apps that reside in the provider-specific FHIR App Store may be designed to utilize patient-centric data and the subject patient's associated FHIR resources to provide individual solutions. In embodiments, the FHIR apps installed from the provider-specific FHIR App Store may be presented on a dashboard associated with the subject patient and provided by the UMR Cloud Network.

    Discovery routing systems and engines

    公开(公告)号:US12051485B2

    公开(公告)日:2024-07-30

    申请号:US17212964

    申请日:2021-03-25

    摘要: The inventive subject matter provides apparatus, systems, and methods that improve on the pace of discovering new practical information based on large amounts of datasets collected. In most cases, anomalies from the datasets are automatically identified, flagged, and validated by a cross-validation engine. Only validated anomalies are then associated with a subject matter expert who is qualified to take action on the anomaly. In other words, the inventive subject matter bridges the gap between the overwhelming amount of scientific data which can now be harvested and the comparatively limited amount analytical resources available to extract practical information from the data. Practical information can be in the form of trends, patterns, maps, hypotheses, or predictions, for example, and such practical information has implications in medicine, in environmental sciences, entertainment, travel, shopping, social interactions, or other areas.